Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 ,inter alia, to consider and approve the Audited Financial Results (Standalone & Consolidate) of the company for the Quarter-IV and Financial Year ended on March 31, 2025